✨ Your Portfolio is fetched and updated from zerodha.
Large
Market Cap
₹1,13,318 Cr.
P/E
98.75

Key Ratios

Market cap
Market cap
1.13 L Cr
PE
PE
98.75
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
11.47
ROCE (%)
ROCE (%)
12.30
Div Yield (%)
Div Yield (%)
-
Sales
Sales
7,513 Cr
OPM (%)
OPM (%)
26.41 %
Debt to Equity
Debt to Equity
-
About
Max Healthcare Inst is in the Miscellaneous sector with a M.cap of 113318.00 Cr and a … Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Max Healthcare Institute Ltd. Business

Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda. It provides services in the areas of cardiology, orthopedics and joint replacement, cancer, neurosciences, pediatrics, obstetrics and gynecology, aesthetics and reconstructive plastic surgery, internal medicine, eye and dental care, endocrinology, diabetes, obesity, ENT, metal health and behavioral sciences, physiotherapy and rehabilitation, and nuclear medicine, as well as minimal access, metabolic, and bariatric surgery.

Max Healthcare Inst major competitors are Apollo Hospital Ent., Fortis Healthcare, Global Health, Narayana Hrudayalay, Aster DM Healthcare, Krishna Inst.Medi, RainbowChildrenS Med.
Market Cap of Max Healthcare Inst is ₹1,14,689 Crs.
While the median market cap of its peers are ₹36,459 Crs.

Max Healthcare Inst seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Aug Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
Investor Presentation Feb May Aug Feb Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material